Drug Type Interleukins, Biosimilar |
Synonyms Oprelvekin biosimilar (Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.), Xin Mei Ge, oprelvekin + [3] |
Target |
Action stimulants |
Mechanism IL-11RA stimulants(Interleukin 11 receptor alpha stimulants), Thrombopoiesis stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (26 Apr 2005), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Thrombocytopenia | China | 26 Apr 2005 |